(Q30571976)

21 August 2017

Regulating specific growth factor signaling using immobilized branched ligands (English)

1 reference

21 August 2017

Michael W Toepke

1

1 reference

21 August 2017

Nicholas A Impellitteri

2

1 reference

21 August 2017

Sheeny K Lan Levengood

3

1 reference

21 August 2017

Derek S Boeldt

4

1 reference

21 August 2017

Ian M Bird

5

1 reference

21 August 2017

William L Murphy

6

1 reference

21 August 2017

11 May 2012

1 reference

Advanced Healthcare Materials

21 August 2017

1 reference

21 August 2017

1

1 reference

21 August 2017

4

1 reference

21 August 2017

457-460

1 reference

Surfaces that sequester serum-borne heparin amplify growth factor activity

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Biomaterials that regulate growth factor activity via bioinspired interactions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Harnessing endogenous growth factor activity modulates stem cell behavior

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

[Ca2+]i signaling vs. eNOS expression as determinants of NO output in uterine artery endothelium: relative roles in pregnancy adaptation and reversal by VEGF165

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Anti-VEGF therapy: comparison of current and future agents

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

The biology of VEGF and its receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

VEGF-Trap: a VEGF blocker with potent antitumor effects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Development of fibrin derivatives for controlled release of heparin-binding growth factors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3925890

Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FADHM.201200077

Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23184776

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ADHM.201200077

1 reference

21 August 2017

1 reference

21 August 2017

1 reference